FDA Drug Policy Office Director Candidate Getting Four-Month Tryout
This article was originally published in The Pink Sheet Daily
Executive Summary
OHOP’s Jonathan Jarow will serve 120-day detail as acting director of CDER’s Office of Medical Policy before FDA makes final decision on permanent head of the office.
You may also be interested in...
FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner
Renowned cardiologist and clinical trialist Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco.
Show Me The Money: FDA Recruitment Efforts Challenged By Government Salaries
FDA’s Center for Drugs continues to operate under a staffing shortage at a time when it faces tremendous pressure to implement new authorities. In some cases, that’s left Janet Woodcock scrambling to find senior managers that can lead top CDER initiatives. Direct hiring authority has helped, but it doesn’t fully address FDA’s recruiting challenges. There’s still too much red tape – and not enough money.
FDA Policy In Biosimilars, “Breakthrough” And Social Media Under New Management
Office of Medical Policy’s leadership gets reshuffled following retirement of the long-time CDER denizen Rachel Sherman.